Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domestic rhFSH for Controlled Ovarian Hyperstimulation in IVF-ET
NCT03071172Phase 3Unknown
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Mar 2017
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of follitropin in infertility (2 arms), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd. Primary endpoint: Total number of oocytes obtained during the start-up period. Status: unknown.
02
Drugs
follitropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03071172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071172.